HYP focuses on US-listed companies experiencing exceptionally high sales growth or showing signs of entering a hypergrowth phase. The fund defines hypergrowth as year-over-year growth of at least 40% in the current quarter and excludes firms below a set sales threshold. Using a proprietary model, it evaluates liquidity, sales growth, and other performance factors to select and weight holdings without regard to market capitalization.